Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

(2019) John N Primrose et al.   LANCET ONCOLOGY

Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach

(2018) Kenichi Komaya et al.   SURGERY

Clinicopathological features and prognosis of advanced biliary carcinoma centered in the cystic duct

(2018) Yoshitsugu Nakanishi et al.   HPB

Clinicopathologic study on metachronous double cholangiocarcinomas of perihilar and subsequent distal bile duct origin

(2017) Kentaro Shinohara et al.   SURGERY

Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma

(2016) Young Saing Kim et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Surgery for Recurrent Biliary Tract Cancer

(2015) Yu Takahashi et al.   ANNALS OF SURGERY

Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma

(2015) Jun Sakata et al.   ANNALS OF SURGICAL ONCOLOGY

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection

(2015) Bas Groot Koerkamp et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Surgical Outcomes of Multicentric Adenocarcinomas of the Biliary Tract

(2011) S. Kobayashi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma

(2009) A. Kobayashi et al.   BRITISH JOURNAL OF SURGERY